Shimizu W - Search Results

1

Impact of Acute Kidney Injury on In-Hospital Outcomes of Patients With Acute Myocardial Infarction　- Results From the Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) Substudy.

Kuji S, Kosuge M, Kimura K, Nakao K, Ozaki Y, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET Investigators. Kuji S, et al. Among authors: shimizu w. Circ J. 2017 Apr 25;81(5):733-739. doi: 10.1253/circj.CJ-16-1094. Epub 2017 Feb 9. Circ J. 2017. PMID: 28179593 Free article.

2

Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease.

Aiba T, Kurita T, Taguchi A, Shimizu W, Suyama K, Aihara N, Kamakura S. Aiba T, et al. Among authors: shimizu w. Circ J. 2002 Apr;66(4):367-71. doi: 10.1253/circj.66.367. Circ J. 2002. PMID: 11954951 Free article.

3

Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction.

Bezzina CR, Shimizu W, Yang P, Koopmann TT, Tanck MW, Miyamoto Y, Kamakura S, Roden DM, Wilde AA. Bezzina CR, et al. Among authors: shimizu w. Circulation. 2006 Jan 24;113(3):338-44. doi: 10.1161/CIRCULATIONAHA.105.580811. Epub 2006 Jan 16. Circulation. 2006. PMID: 16415376

4

Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.

Ohashi J, Yasuda S, Miyazaki S, Shimizu W, Morii I, Kurita T, Kawamura A, Kamakura S, Nonogi H. Ohashi J, et al. Among authors: shimizu w. J Cardiovasc Pharmacol. 2006 Dec;48(6):274-9. doi: 10.1097/01.fjc.0000248242.99337.4d. J Cardiovasc Pharmacol. 2006. PMID: 17204905 Clinical Trial.

5

Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S. Moss AJ, et al. Among authors: shimizu w. Circulation. 2007 May 15;115(19):2481-9. doi: 10.1161/CIRCULATIONAHA.106.665406. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470695 Free PMC article.

6

Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome.

Nagaoka I, Shimizu W, Itoh H, Yamamoto S, Sakaguchi T, Oka Y, Tsuji K, Ashihara T, Ito M, Yoshida H, Ohno S, Makiyama T, Miyamoto Y, Noda T, Kamakura S, Akao M, Horie M. Nagaoka I, et al. Among authors: shimizu w. Circ J. 2008 May;72(5):694-9. doi: 10.1253/circj.72.694. Circ J. 2008. PMID: 18441445 Free article.

7

Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.

Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H; J-RHYTHM Investigators. Ogawa S, et al. Circ J. 2009 Feb;73(2):242-8. doi: 10.1253/circj.cj-08-0608. Epub 2008 Dec 8. Circ J. 2009. PMID: 19060419 Free article. Clinical Trial.

8

QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy.

Nagai T, Kurita T, Satomi K, Noda T, Okamura H, Shimizu W, Suyama K, Aihara N, Kobayashi J, Kamakura S. Nagai T, et al. Among authors: shimizu w. Circ J. 2009 Jun;73(6):1028-32. doi: 10.1253/circj.cj-08-0744. Epub 2009 Apr 10. Circ J. 2009. PMID: 19359812 Free article.

9

Predictors of electrical storm in patients with idiopathic dilated cardiomyopathy--how to stratify the risk of electrical storm.

Takigawa M, Noda T, Kurita T, Aihara N, Yamada Y, Okamura H, Satomi K, Suyama K, Shimizu W, Kamakura S. Takigawa M, et al. Among authors: shimizu w. Circ J. 2010 Sep;74(9):1822-9. doi: 10.1253/circj.cj-10-0092. Epub 2010 Jul 29. Circ J. 2010. PMID: 20679735 Free article.

10

Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement?

Kawata H, Noda T, Kurita T, Yamagata K, Yamada Y, Okamura H, Satomi K, Shimizu W, Suyama K, Aihara N, Isobe M, Kamakura S. Kawata H, et al. Among authors: shimizu w. Circ J. 2010 Nov;74(11):2301-7. doi: 10.1253/circj.cj-10-0316. Epub 2010 Sep 18. Circ J. 2010. PMID: 20877125 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

887 results

Search Page